i.Close out your day
Fifteen minutes. Every weekday. Everything that moved.
Trial readouts, FDA decisions, deals, and money moves — the whole industry beat, distilled into one tight brief you can finish before your first meeting.
Browse all episodes → Latest episode
Loading episodes…
Listen on Spotify →ii.Close out the deal
Walk into the room knowing which deals actually worked.
Pharma deal intelligence with scoring where assessable — from Wall Street's announcement-day call to how deals aged. The market-intelligence layer for BD, CI, and commercial teams — yours to use, not your company's to license.
Flagship study
The Hype Gap
What Wall Street's deal-day verdict got wrong — measured across 828 dual-graded deals.
43%of graded deals: consensus missed the outcome by 25+ points
Read the study →
The record
1,500+published deal records, scoring where assessable
Deal Library
Search the full deal record. Where assessable, see the scorecard and receipts.
Browse deals →iii.The daily close, in writing
The brief you can forward, cite, and keep.
Audio disappears after you hear it. The written close persists — for the people who reference it in leadership meetings.
Latest from the newsletter
Jasper's Rescue Deal Is a Bet on Two Drugs It Almost Buried
Novo Just Turned Its Injectable Habit Into a European Moat
Biogen Wants to File a Trial That Missed Its Primary Endpoint
GSK Paid $10.6 Billion for Two FDA Dates It Doesn't Control
Loading articles…
Join free — get the report
AI in Pharma: The 2026 Reckoning
Our research report on where AI actually lands in pharma — free when you subscribe to the newsletter.
Subscribes you on Substack · the report arrives in your welcome email.